Guaifenesin
- Product NDC
- 69618-061
- 11-digit product format
- 696180061
- Labeler code
- 69618
- Product ID
- 69618-061_2bc81e27-90e3-930d-e063-6394a90a699d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Reliable 1 Laboratories LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-08-01
- Substance
- GUAIFENESIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 400 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 359601 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ae469d4f-91c4-cff0-e053-2995a90a0497 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69618-061-06 | 2023-03-29 | C162847 | 48780-1 | f386c649-d238-0266-e053-dadaa90a7c1a | Guifenisen 400 mg |
| 69618-061-06 | 2023-01-30 | C162847 | 48780-1 | f386c649-d238-0266-e053-dadaa90a7c1a | Guifenisen 400 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69618-061-06 | Guaifenesin | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69618-061-06 | EA - Each | 69618-061 | 9467aaf0-ae81-4301-a553-1077f9182d44 | 1 | 2021-03-02 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Childrens Cough Mucus Relief | DEXTROMETHORPHANN HBR, GUAIFENESIN | Discount Drug Mart | 2c27aca4-e1e2-419a-84c4-857718ca49da | 2023-12-29 | Warnings | M012 |
| Night Time Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Walgreen Company | de2b2e34-62a5-451f-ab68-531d1c9d4d82 | 2023-12-29 | Warnings | M012 |
| H E B MAX SEVERE CONGESTION and COUGH Maxium Strength | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | H E B | d2b016ee-5329-45bf-9d71-d626204169cf | 2023-12-29 | Warnings | M012 |
| Tussin DM Cough and Chest Congestion | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | DeMoulas Market Basket | e92d2f64-9690-42d3-b787-cafade3a8999 | 2023-12-29 | Warnings | M012 |
| Cold and Sinus Maxium Strength | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | DeMoulas Market Basket | 6e5ca8e1-5a03-4e77-b385-d44387fb3bfc | 2023-12-29 | Warnings | M012 |
| Cold, Flu and Sore Throat Maxium Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | DeMoulas Market Basket | d98029c0-ccd9-47e1-996f-c7786cd4ecca | 2023-12-29 | Warnings | M012 |
| MAXIMUM STRENGTH Sinus Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE | Topco Associates LLC | 0f2be061-bd0a-4e62-b994-6d0768ea647a | 2023-12-29 | Warnings | M012 |
| Tussin CF Multi-Symptom Cold | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | DeMoulas Market Basket | c19b9997-4037-48f3-b905-86da421a292d | 2023-12-29 | Warnings | M012 |
| HempNesic | MENTHOL, CAMPHOR | Blaine Labs Inc. | 0239ada0-644d-4ef4-a3b8-df70246a3bc2 | 2023-12-21 | Warnings | M012 |
| HempNesic | MENTHOL, CAMPHOR | Blaine Labs Inc. | a698502d-c1c5-41ca-8142-74338b834c8b | 2023-12-21 | Warnings | M012 |
| Father Johns Cough Medicine Plus | NASAL DECONGESTANT | Oakhurst Company | 8b8aab0f-251b-6bd8-e053-2995a90ad748 | 2023-12-18 | Warnings | M012 |
| Father Johns Medicine | DEXTROMETHORPHAN HBR | Oakhurst Company | 8b8a249d-55af-cc98-e053-2995a90a431d | 2023-12-18 | Warnings | M012 |
| Daytime Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL TABLET, FILM-COATED | Lil' Drug Store Products, Inc. | e79d92d2-d73c-d44f-e053-2995a90a03d9 | 2023-12-15 | Warnings | M012 |
| Allergy | DIPHENHYDRAMINE HCL TABLET | Lil' Drug Store Products, Inc. | e5339c39-1d66-b283-e053-2995a90a4317 | 2023-12-15 | Warnings | M012 |
| Father Johns Medicine | DEXTROMETHORPHAN HBR | Humco Holding Group, Inc | a7b0669f-8da1-5a44-e053-2995a90a84d9 | 2023-12-15 | Warnings | M012 |
| Ephedrine Hydrochloride | EPHEDRINE HYDROCHLORIDE | Walgreen Company | bcb81dc1-d854-30c0-e053-2a95a90a9fc7 | 2023-12-14 | Warnings | M012 |
| Allergy, Circle K | DIPHENHYDRAMINE HCL 25MG TABLET | Lil' Drug Store Products, Inc. | d1f370ac-e7f4-baf7-e053-2995a90a1e50 | 2023-12-14 | Warnings | M012 |
| Circle K Allergy Antihistamine | DIPHENHYDRAMINE HYDROCHLORIDE | Lil' Drug Store Products, Inc. | a6a1e3d9-575c-4adf-beb6-c9719de55c67 | 2023-12-14 | Warnings | M012 |
| Non-Drowsy Sinus Severe, Circle K | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL CAPLET, FILM-COATED | Lil' Drug Store products, Inc. | e78c456f-f62e-596d-e053-2995a90a2397 | 2023-12-14 | Warnings | M012 |
| Non-Drowsy Max Cold | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCI TABLET, FILM-COATED | Lil' Drug Store Products, Inc. | e79f1a92-d8ea-e3f9-e053-2a95a90a2d37 | 2023-12-14 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 359601 | guaiFENesin 400 MG Oral Tablet | PSN | 570a71eb-2d19-4c7b-8c00-e1524bfa3844 | 102 |
| 359601 | guaifenesin 400 MG Oral Tablet | SCD | 570a71eb-2d19-4c7b-8c00-e1524bfa3844 | 102 |
| 359601 | guaiFENesin 400 MG Oral Tablet | PSN | ae469d4f-91c4-cff0-e053-2995a90a0497 | 5 |
| 359601 | guaifenesin 400 MG Oral Tablet | SCD | ae469d4f-91c4-cff0-e053-2995a90a0497 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69618-061-06 | 69618006106 | 60 TABLET in 1 BOTTLE, PLASTIC (69618-061-06) | 60 tablet | 2020-08-01 | 0000-00-00 | No | No | Current |